Global Peripheral Vascular Interventional Devices Market Growth (Status and Outlook) 2026-2032
Description
The global Peripheral Vascular Interventional Devices market size is predicted to grow from US$ 10932 million in 2025 to US$ 18061 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032.
Peripheral Vascular Interventional Devices refer to minimally invasive medical devices used for the diagnosis and treatment of non-coronary vascular diseases, including peripheral arteries, veins, and lymphatic systems. These products mainly include balloon catheters, vascular stents, guidewires, catheters, thrombectomy devices, and drug-coated devices. Guided by imaging technologies such as DSA, CT, or ultrasound, these devices are introduced into target vessels through percutaneous access to dilate, reconstruct, or restore blood flow. They are widely used in the treatment of peripheral artery disease (PAD), deep vein thrombosis (DVT), arteriovenous fistula, and tumor interventions. With advantages such as minimal trauma, faster recovery, and lower complication risks, these devices are increasingly replacing traditional surgical approaches and represent a key trend toward precision, minimally invasive, and personalized vascular therapy.The average gross profit margin of this product is 73%.
The rising incidence of peripheral vascular diseases, driven by aging populations and the prevalence of chronic conditions such as diabetes and hypertension, continues to support long-term demand for interventional therapies. Meanwhile, healthcare systems are increasingly shifting toward minimally invasive approaches, and optimized clinical pathways are enhancing procedure penetration. Technological advancements, including drug-coated balloons, bioresorbable stents, and image-guided navigation systems, are improving treatment outcomes and expanding clinical indications. In addition, improving healthcare infrastructure and broader insurance coverage in emerging markets provide sustained growth momentum.The sector features high technical barriers, long development cycles, and stringent clinical validation requirements, while increasingly strict regulatory frameworks raise entry thresholds. Leading multinational companies dominate the high-end segment, creating strong barriers in branding, distribution, and physician relationships for new entrants. Pricing pressures from centralized procurement and cost-control policies further constrain profitability. Moreover, variations in operator experience and potential procedural complications still pose challenges to wider adoption.Clinical demand is shifting toward higher-performance devices, particularly those capable of treating long lesions, reducing restenosis rates, and offering improved operability. Treatment settings are gradually expanding from top-tier hospitals to primary healthcare institutions, driving demand for standardized and user-friendly products. The rise of day-surgery models and fast recovery concepts further increases the attractiveness of low-trauma, short-procedure devices. Additionally, growing demand in tumor interventions and venous disease treatment is creating new opportunities in niche segments.Upstream materials mainly include medical-grade polymers (such as PTFE and nylon), metallic materials (such as nitinol and stainless steel), and functional coating materials. High-performance materials are critical in determining device flexibility, radial strength, and biocompatibility. Currently, high-end raw materials still rely partly on imports, making supply chain stability a key concern. With ongoing advancements in domestic material technologies and accelerating localization, cost structures are expected to improve, although higher requirements for quality consistency and process control will emerge.
LPI (LP Information)' newest research report, the “Peripheral Vascular Interventional Devices Industry Forecast” looks at past sales and reviews total world Peripheral Vascular Interventional Devices sales in 2025, providing a comprehensive analysis by region and market sector of projected Peripheral Vascular Interventional Devices sales for 2026 through 2032. With Peripheral Vascular Interventional Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Vascular Interventional Devices industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Vascular Interventional Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peripheral Vascular Interventional Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripheral Vascular Interventional Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Vascular Interventional Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Vascular Interventional Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Vascular Interventional Devices market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stent
Catheter
Guidewire
Sheath
Vena Cava Filter
Other
Segmentation by Diseases:
Arterial Diseases
Venous Diseases
Segmentation by Material:
Metallic Devices
Polymer Devices
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
BD
Biotronik
Boston Scientific
Medtronic
Merit Medical
Terumo
Teleflex
Cook Medical
Cordis
Alvimedica
Lepu Medical
Zylox-Tonbridge Medical
Endovastec
ACOTEC
LifeTech Scientific
WEGO
Brosmed
DK MEDTECH
Barty Medical
Please note: The report will take approximately 2 business days to prepare and deliver.
Peripheral Vascular Interventional Devices refer to minimally invasive medical devices used for the diagnosis and treatment of non-coronary vascular diseases, including peripheral arteries, veins, and lymphatic systems. These products mainly include balloon catheters, vascular stents, guidewires, catheters, thrombectomy devices, and drug-coated devices. Guided by imaging technologies such as DSA, CT, or ultrasound, these devices are introduced into target vessels through percutaneous access to dilate, reconstruct, or restore blood flow. They are widely used in the treatment of peripheral artery disease (PAD), deep vein thrombosis (DVT), arteriovenous fistula, and tumor interventions. With advantages such as minimal trauma, faster recovery, and lower complication risks, these devices are increasingly replacing traditional surgical approaches and represent a key trend toward precision, minimally invasive, and personalized vascular therapy.The average gross profit margin of this product is 73%.
The rising incidence of peripheral vascular diseases, driven by aging populations and the prevalence of chronic conditions such as diabetes and hypertension, continues to support long-term demand for interventional therapies. Meanwhile, healthcare systems are increasingly shifting toward minimally invasive approaches, and optimized clinical pathways are enhancing procedure penetration. Technological advancements, including drug-coated balloons, bioresorbable stents, and image-guided navigation systems, are improving treatment outcomes and expanding clinical indications. In addition, improving healthcare infrastructure and broader insurance coverage in emerging markets provide sustained growth momentum.The sector features high technical barriers, long development cycles, and stringent clinical validation requirements, while increasingly strict regulatory frameworks raise entry thresholds. Leading multinational companies dominate the high-end segment, creating strong barriers in branding, distribution, and physician relationships for new entrants. Pricing pressures from centralized procurement and cost-control policies further constrain profitability. Moreover, variations in operator experience and potential procedural complications still pose challenges to wider adoption.Clinical demand is shifting toward higher-performance devices, particularly those capable of treating long lesions, reducing restenosis rates, and offering improved operability. Treatment settings are gradually expanding from top-tier hospitals to primary healthcare institutions, driving demand for standardized and user-friendly products. The rise of day-surgery models and fast recovery concepts further increases the attractiveness of low-trauma, short-procedure devices. Additionally, growing demand in tumor interventions and venous disease treatment is creating new opportunities in niche segments.Upstream materials mainly include medical-grade polymers (such as PTFE and nylon), metallic materials (such as nitinol and stainless steel), and functional coating materials. High-performance materials are critical in determining device flexibility, radial strength, and biocompatibility. Currently, high-end raw materials still rely partly on imports, making supply chain stability a key concern. With ongoing advancements in domestic material technologies and accelerating localization, cost structures are expected to improve, although higher requirements for quality consistency and process control will emerge.
LPI (LP Information)' newest research report, the “Peripheral Vascular Interventional Devices Industry Forecast” looks at past sales and reviews total world Peripheral Vascular Interventional Devices sales in 2025, providing a comprehensive analysis by region and market sector of projected Peripheral Vascular Interventional Devices sales for 2026 through 2032. With Peripheral Vascular Interventional Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Vascular Interventional Devices industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Vascular Interventional Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peripheral Vascular Interventional Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripheral Vascular Interventional Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Vascular Interventional Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Vascular Interventional Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Vascular Interventional Devices market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stent
Catheter
Guidewire
Sheath
Vena Cava Filter
Other
Segmentation by Diseases:
Arterial Diseases
Venous Diseases
Segmentation by Material:
Metallic Devices
Polymer Devices
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
BD
Biotronik
Boston Scientific
Medtronic
Merit Medical
Terumo
Teleflex
Cook Medical
Cordis
Alvimedica
Lepu Medical
Zylox-Tonbridge Medical
Endovastec
ACOTEC
LifeTech Scientific
WEGO
Brosmed
DK MEDTECH
Barty Medical
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
121 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Peripheral Vascular Interventional Devices Market Size by Player
- 4 Peripheral Vascular Interventional Devices by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Peripheral Vascular Interventional Devices Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
